{"pub": "investingcom", "url": "https://ca.investing.com/news/stock-market-news/briefaurinia-establishes-atthemarket-facility-1967859", "downloaded_at": "2019-09-14 02:02:16.169439+00:00", "title": "BRIEF-Aurinia Establishes At-The-Market Facility", "language": "en", "text": "BRIEF-Aurinia Establishes At-The-Market Facility\n\nStock Markets 3 hours ago (Sep 13, 2019 18:30)\n\n\u00a9 Reuters. BRIEF-Aurinia Establishes At-The-Market Facility Aurinia Pharmaceuticals Inc : * AURINIA ESTABLISHES AT-THE-MARKET FACILITY * AURINIA PHARMACEUTICALS INC - MAY SELL THROUGH AT-THE-MARKET OFFERINGS COMMON SHARES HAVING AN AGGREGATE OFFER PRICE OF UP TO US$40 MILLION * AURINIA PHARMACEUTICALS INC - INTENDS TO USE SALES PROCEEDS TO FUND ITS DRY EYE SYNDROME PROGRAM AND COSTS RELATED TO VOCLOSPORIN\n\nBRIEF-Aurinia Establishes At-The-Market Facility", "description": "BRIEF-Aurinia Establishes At-The-Market Facility", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEB0508S_L.jpg", "published_at": "2019-09-13"}